Mukesh Choudhary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mukesh Choudhary has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Bharti Mohan
Department of Chemistry, National Institute of Technology Patna, Patna-800005, India
12 shared publicationsSulakshna Bharti
Department of Chemistry National Institute of Technology Patna Patna 800005 (Bihar India
8 shared publications- Shabbir Muhammad
Department of Chemistry, College of Science, King Khalid University, Abha, Saudi Arabia
7 shared publications Sunil Kumar
7 shared publications- Kartini Ahmad
Department of Chemistry, National Institute of Technology Patna
6 shared publications Santosh Kumar
Division of Chemical Engineering, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea
6 shared publications
Latest Publications
- 24 July 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1377
Synthesis, characterization and bio-functional properties of Cd(II) and Co(III) coordination complexes
- 24 July 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1377
Synthesis, characterization and bio-functional properties of Cd(II) and Co(III) coordination complexes
- 6 December 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1355
A phenoxy-oxygen bridged cadmium (II) complex: synthesis, structural characterization and enhanced biological activities
- 6 December 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1355
A phenoxy-oxygen bridged cadmium (II) complex: synthesis, structural characterization and enhanced biological activities
- 27 November 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1354
New Mn(III) coordination complexes with cis-N2O2 donor ligands: Synthesis, structures, biological activities and theoretical study
- 27 November 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1354
New Mn(III) coordination complexes with cis-N2O2 donor ligands: Synthesis, structures, biological activities and theoretical study
- 17 October 2025
- Published by Elsevier in Inorganica Chimica Acta
- Vol. 590
Copper(II) complex as SARS-CoV-2 Nirmatrelvir inhibitor: Synthesis, crystal structure, anticancer and antiviral properties
- 17 October 2025
- Published by Elsevier in Inorganica Chimica Acta
- Vol. 590
Copper(II) complex as SARS-CoV-2 Nirmatrelvir inhibitor: Synthesis, crystal structure, anticancer and antiviral properties
- 19 June 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (28) , 12401-12422
Synthesis and design of manganese and nickel complexes with potential anticancer and antibacterial activities and antiviral properties for therapeutic applications
Two new triclinic coordination complexes, [M(L)2]·solvent {M = Mn(III) (1) and Ni(II) (2), L = synthesized tridentate Schiff base (SB) ligand, and solvent = DMF for complex (1) and DMSO for complex (2)}, were synthesized via a solvent-controlled reaction of Mn(OAc)3·2H2O/Ni(OAc)2·4H2O with SB. The solid-state structures of complexes (1) and (2) were determined using single crystal X-ray crystallography, which revealed a distorted octahedral geometry. Quantum computational calculations provided the structure–activity relationship. Hirshfeld surfaces were used to visualize and analyze intermolecular interactions. The CT-DNA and BSA protein binding interaction ability of complexes (1) and (2) were explored using a UV-visible study. To gain insights into the potential biological applications, a superior biological activity study (in vitro cytotoxicity) was conducted for investigating the effects of complexes (1) and (2) on breast cancer (MCF-7), cervical cancer (HeLa) and lung cancer (A549) cell lines, which were compared with those on the human normal kidney epithelial (NKE) cell line. Moreover, complexes (1) and (2) were tested for in vitro antibacterial activity. Besides biological potentials, we examined the antiviral molecular docking of complexes (1) and (2) with SARS-CoV-2 proteins (PDB ID: 8FXC, 6M0J and 8DV1), SARS-CoV-2 Omicron viral RBD proteins (PDB ID: 7TN0 and 7WBP) and a DNA-binding protein (PDB ID: 7UR0). The complexes showed good inhibition performance with the intended drug targets of the viral proteins and may be used as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs. Both the triclinic Mn(III) and Ni(II) complexes showed superior biological characteristics and antiviral properties for therapeutic applications.
- 19 June 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (28) , 12401-12422
Synthesis and design of manganese and nickel complexes with potential anticancer and antibacterial activities and antiviral properties for therapeutic applications
Two new triclinic coordination complexes, [M(L)2]·solvent {M = Mn(III) (1) and Ni(II) (2), L = synthesized tridentate Schiff base (SB) ligand, and solvent = DMF for complex (1) and DMSO for complex (2)}, were synthesized via a solvent-controlled reaction of Mn(OAc)3·2H2O/Ni(OAc)2·4H2O with SB. The solid-state structures of complexes (1) and (2) were determined using single crystal X-ray crystallography, which revealed a distorted octahedral geometry. Quantum computational calculations provided the structure–activity relationship. Hirshfeld surfaces were used to visualize and analyze intermolecular interactions. The CT-DNA and BSA protein binding interaction ability of complexes (1) and (2) were explored using a UV-visible study. To gain insights into the potential biological applications, a superior biological activity study (in vitro cytotoxicity) was conducted for investigating the effects of complexes (1) and (2) on breast cancer (MCF-7), cervical cancer (HeLa) and lung cancer (A549) cell lines, which were compared with those on the human normal kidney epithelial (NKE) cell line. Moreover, complexes (1) and (2) were tested for in vitro antibacterial activity. Besides biological potentials, we examined the antiviral molecular docking of complexes (1) and (2) with SARS-CoV-2 proteins (PDB ID: 8FXC, 6M0J and 8DV1), SARS-CoV-2 Omicron viral RBD proteins (PDB ID: 7TN0 and 7WBP) and a DNA-binding protein (PDB ID: 7UR0). The complexes showed good inhibition performance with the intended drug targets of the viral proteins and may be used as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs. Both the triclinic Mn(III) and Ni(II) complexes showed superior biological characteristics and antiviral properties for therapeutic applications.
- 17 August 2024
- Published by Taylor & Francis in Journal of Coordination Chemistry
- Vol. 77 (15-16) , 1821-1844
Design, structure and antivirus molecular docking of chloridobis(1,10-phenanthroline)-(thiocyanato)-copper(II)
- 17 August 2024
- Published by Taylor & Francis in Journal of Coordination Chemistry
- Vol. 77 (15-16) , 1821-1844
Design, structure and antivirus molecular docking of chloridobis(1,10-phenanthroline)-(thiocyanato)-copper(II)
- 14 August 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (34) , 15053-15076
Design and synthesis of copper( ii ) and nickel( ii ) complexes as potential inhibitors against SARS-CoV-2 viral RNA binding protein and Omicron RBD protein
Two bis-Schiff base metal( ii ) complexes [Cu(L) 2 ](1) and [Ni(L) 2 ](2) were designed and synthesized as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron and anti-HIV drugs.
- 14 August 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (34) , 15053-15076
Design and synthesis of copper( ii ) and nickel( ii ) complexes as potential inhibitors against SARS-CoV-2 viral RNA binding protein and Omicron RBD protein
Two bis-Schiff base metal( ii ) complexes [Cu(L) 2 ](1) and [Ni(L) 2 ](2) were designed and synthesized as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron and anti-HIV drugs.
- 3 May 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (20) , 9287-9313
Synthesis of Zn( ii ) coordination complexes, their molecular design and docking with SARS-CoV-2 RBD protein and Omicron spike protein
Two Zn( ii ) complexes [Zn(L)(en)]ClO 4 (1) and [Zn(L) 2 ] (2) were synthesized and designed and their molecular docking with the SARS-CoV-2 RBD protein and Omicron spike protein were studied for assessing them as possible therapeutic drug candidates against SARS-CoV-2 and its Omicron variant.
- 3 May 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (20) , 9287-9313
Synthesis of Zn( ii ) coordination complexes, their molecular design and docking with SARS-CoV-2 RBD protein and Omicron spike protein
Two Zn( ii ) complexes [Zn(L)(en)]ClO 4 (1) and [Zn(L) 2 ] (2) were synthesized and designed and their molecular docking with the SARS-CoV-2 RBD protein and Omicron spike protein were studied for assessing them as possible therapeutic drug candidates against SARS-CoV-2 and its Omicron variant.
- 20 February 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (3) , 895-915
Unusual Ni⋯Ni interaction in Ni( ii ) complexes as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs
In this study, two nickel( ii ) coordination complexes [Ni(L)] 2 (1) and [Ni(L)] n (2) of a tetradentate-N 2 O 2 donor Schiff base ligand ( H 2 L ) were synthesized, designed and characterized via spectroscopic and SC-XRD analysis, and molecular docking study.
- 20 February 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (3) , 895-915
Unusual Ni⋯Ni interaction in Ni( ii ) complexes as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs
In this study, two nickel( ii ) coordination complexes [Ni(L)] 2 (1) and [Ni(L)] n (2) of a tetradentate-N 2 O 2 donor Schiff base ligand ( H 2 L ) were synthesized, designed and characterized via spectroscopic and SC-XRD analysis, and molecular docking study.